A Novel ω-3 Acid Ethyl Ester Formulation Incorporating Advanced Lipid TechnologiesTM (ALT®) Improves Docosahexaenoic Acid and Eicosapentaenoic Acid Bioavailability Compared with Lovaza®
Autor: | Lopez-Toledano, Miguel A., Thorsteinsson, Thorsteinn, Daak, Ahmed, Maki, Kevin C., Johns, Colleen, Rabinowicz, Adrian L., Sancilio, Frederick D. |
---|---|
Zdroj: | In Clinical Therapeutics March 2017 39(3):581-591 |
Databáze: | ScienceDirect |
Externí odkaz: |